Previous studies have investigated whether MetS is related to lower urinary tract symptoms (LUTS) resulting from BPH [16] and the relationship between the SNPs (rs4646 and rs700518) of CYP19A1 and estrogen and MetS-BPH [15]. This evidence concerns the gene CYP19A1 and benign prostatic hyperplasia.